The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer centers adapt to life without site visits as NIH changes CCSG review

Cancer Policy

Paychecks stop for HHS workers as shutdown continues

NEJM, public health group to launch alternate publication to CDC’s MMWR

Senators, nonprofits respond to Trump’s avowed support for IVF

Shutdown precluded NCI officials from appearing at AACI/CCAF annual meeting

Science advocates organize march in DC to demand impeachment of RFK Jr.

Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA

Clinical Roundup

Ozekibart improves PFS in chondrosarcoma, registrational phase II trial shows

Targeted radiation during surgery reduces pancreatic cancer recurrence, Hopkins study finds

Drugs approved for pain also reduce bone cancer growth, Hopkins-led pre-clinical study finds

Researchers develop technique to track chemotherapy drug inside cells

Shortened version of HER2 protein may drive treatment resistance in breast cancer, Mayo study finds

Enhancing the body’s “first responder” cells may boost immune therapy, Mayo study finds

In The Clinic

GRAIL to use new study results to seek FDA approval of Galleri MCD test

FreeTrials & Tribulations
Regulatory NewsTrials & Tribulations
Trials & Tribulations
Conversation with The Cancer Letter

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account